• Epidemiology and risk factors
• 30 min
  1. Epidemiology of COPD

  • Dr. David Mannino
• 36 min
  2. COPD in never smokers

  • Dr. Sundeep Salvi
• 43 min
  3. Genetics of chronic obstructive pulmonary disease (COPD)

  • Prof. Martin Tobin
• Phenotypes of COPD
• 44 min
  4. COPD and asthma: similarities and differences

  • Prof. Peter Barnes
• Pathophysiology and mechanisms of COPD
• 43 min
  5. The pathology of chronic obstructive pulmonary disease

  • Prof. James Hogg
• 63 min
  6. The continuum of COPD: a physiological perspective

  • Prof. Denis O'Donnell
• 47 min
  7. Inflammatory and immune mechanisms in COPD

  • Prof. Peter Barnes
• 44 min
  8. Mechanisms of COPD exacerbations and relation to exacerbation therapy

  • Prof. Wisia Wedzicha
• 39 min
  9. Protease-antiprotease balance

  • Prof. Robert Stockley
• Therapy and management
• 42 min
  10. Updates in chronic obstructive pulmonary disease (COPD)

  • Dr. Omar S. Usmani
• 45 min
  11. Long-acting bronchodilators in COPD

  • Prof. Bart Celli
• 54 min
  12. Treatment of COPD exacerbations

  • Prof. Antonio Anzueto
• 25 min
  13. Pulmonary rehabilitation: history, promise and problems

  • Prof. Richard Casaburi
• 29 min
  14. Lung volume reduction: advances in COPD

  • Dr. Nick Hopkinson
• 35 min
  15. New pharmacological therapies for COPD

  • Prof. Peter Barnes
• 32 min
  16. The Salford lung study in COPD

  • Dr. Dave Leather
• COPD case studies
• 11 min
  17. COPD treatment case I: COPD with “bronchitis attacks”

  • Dr. Janwillem Kocks
• 13 min
  18. COPD treatment case II: COPD with asthma as child

  • Dr. Janwillem Kocks
• 12 min
  19. COPD treatment case III: COPD with pre-diabetes

  • Dr. Janwillem Kocks
• 48 min
  20. Tailoring care for advanced COPD

  • Prof. Wissam Chatila
• Archived Lectures *These may not cover the latest advances in the field
• 59 min
  21. Alpha-1 antitrypsin deficiency: state of the art

  • Dr. Jamie Stoller
• 34 min
  22. Oxidative stress in COPD

  • Prof. William MacNee
• 24 min
  23. Managing co-morbidity in COPD

  • Dr. John Hurst
• 40 min
  24. Clinical phenotypes of COPD

  • Prof. Jørgen Vestbo
• 27 min
  25. Pulmonary rehabilitation: focusing on rehabilitative exercise

  • Prof. Richard Casaburi
• 36 min
  26. Genetics of COPD

  • Prof. Ian Hall

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Outline
3. Dr. Alvan Barach (1)
4. Dr. Alvan Barach (2)
5. Dr. Alvan Barach (3)
6. Dr. Alvan Barach (4)
7. Dr. Thomas L. Petty
8. Pulmonary rehabilitation for COPD (1)
9. Comprehensive care program
10. Pulmonary rehabilitation for COPD (2)
11. Pulmonary rehabilitation recognition
12. The dark ages
13. Futility of exercise training (1)
14. Futility of exercise training (2)
15. Belman and Kendregan, 1981 (1)
16. Belman and Kendregan, 1981 (2)
17. Belman, 1986
18. The long road
19. What makes pulmonary rehabilitation so effective?
20. Characteristics of an effective training program (1)
21. Characteristics of an effective training program (2)
22. Endurance exercise training at maximal targets
23. We are all heroes of our own story
24. Mediation of reduced ventilatory response
25. Mechanism of the reduction
26. Exercise training in pulmonary rehabilitation
27. Physiologic training effect in COPD (1)
28. Effect of exercise training in COPD (1)
29. Effect of exercise training in COPD (2)
30. Physiologic training effect in COPD (2)
31. Skeletal muscle adaptation to endurance training
32. Skeletal muscle dysfunction in COPD
33. Skeletal muscle dysfunction: mechanisms
34. A physiologic approach to exercise training (1)
35. Contractile leg fatigue after cycle exercise
36. A physiologic approach to exercise training (2)
37. Reduction in dynamic hyperinflation
38. Hyperinflation study methods
39. Effect of exercise on oxygen uptake and ventilation
40. Effect of exercise during constant work rate
41. Effect of exercise on breathing and hyperinflation
42. Endurance training reduces ventilatory drive
43. Optimization
44. Optimization of rehabilitative exercise training
45. Where are we today?
46. Pulmonary rehabilitation guidelines
47. Evidence based rehabilitation guidelines (1)
48. Evidence based rehabilitation guidelines (2)
49. Are other benefits possible?
50. A paradigm shift for pulmonary rehabilitation
51. Activity promotion as goal for COPD patients (1)
52. COPD patients are inactive (1)
53. COPD patients are inactive (2)
54. Activity promotion as goal for COPD patients (2)
55. Physical activity - the strongest mortality predictor
56. Do current therapies increase activity level?
57. Is activity level increased by rehabilitation?
58. Activity promotion in COPD: a paradigm shift
59. Concluding remarks

Topics Covered

• Pulmonary Rehabilitation
• Historical perspective on pulmonary rehabilitation
• Current evidence-based guidelines for pulmonary rehabilitation
• Activity promotion as a novel goal for pulmonary rehabilitation

Links

Series:

• Advances in Chronic Obstructive Pulmonary Disease (COPD)

Categories:

• Clinical Practice

Therapeutic Areas:

• Immunology & Inflammation
• Respiratory Diseases

Talk Citation

Publication History

• Published on July 31, 2012
• Archived on July 31, 2022

Financial Disclosures

• Prof. Richard Casaburi has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.